%0 Journal Article
%T Scalp In-Transit Metastatic Melanoma Treated with Interleukin-2 and Pulsed Dye Laser
%A Michael Z. Wang
%A Jerry D. Brewer
%J Healthcare
%D 2013
%I MDPI AG
%R 10.3390/healthcare1010096
%X No particular regimen is considered standard therapy for widespread metastatic melanoma, although surgery is the primary choice for regional nodal metastases. Systemic interleukin-2 (IL-2) is an effective immunotherapy for melanoma, but standard doses are associated with severe toxicity. We report a patient who was treated with intralesional low-dose IL-2 and V-beam pulsed dye laser for the treatment of scalp melanoma metastases. This treatment resulted in rapid regression of metastatic tumors with limited adverse effects.
%K interleukin-2
%K melanoma
%K pulsed dye laser therapy
%U http://www.mdpi.com/2227-9032/1/1/96